Mural inflammation in Crohn disease: Location-matched histologic validation of MR imaging features

Radiology

Volumn 252, Issue 3, 2009, Pages 712-720

  Punwani, Shonit ^a,b   Rodriguez Justo, Manuel ^a   Bainbridge, Alan ^a   Greenhalgh, Rebecca ^a   De Vita, Enrico ^a   Bloom, Stuart ^a   Cohen, Richard ^a   Windsor, Alastair ^a   Obichere, Austin ^a   Hansmann, Anika ^a   Novelli, Marco ^a   Halligan, Steve ^a,b   Taylor, Stuart A ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; MANNITOL; SCOPOLAMINE BUTYL BROMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC IMAGING; ELECTIVE SURGERY; ENTERITIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; INTESTINE WALL; MAGNETIC RESONANCE ENTEROGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SMALL INTESTINE RESECTION; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; CONTRAST MEDIA; CROHN DISEASE; FEMALE; GADOLINIUM DTPA; HUMANS; INFLAMMATION; INTESTINE, SMALL; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 70349296937     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2523082167     Document Type: Article

References (30)

1. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1(8167):514.
2. Beck IT. Laboratory assessment of inflammatory bowel disease. Dig Dis Sci 1987;32(12 suppl):26S-41S.
3. Singleton JW. Clinical activity assessment in inflammatory bowel disease. Dig Dis Sci 1987;32(12 suppl):42S-45S.
4. Cellier C, Sahmoud T, Froguel E, et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease: a prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut 1994;35(2):231-235.
5. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002;122(2):512-530.
6. Gore RM, Balthazar EJ, Ghahremani GG, Miller FH. CT features of ulcerative colitis and Crohn's disease. AJR Am J Roentgenol 1996;167(1):3-15. (Pubitemid 26196899)
7. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70(3):439-444.
8. Jørgensen LG, Fredholm L, Hyltoft Petersen P, Hey H, Munkholm P, Brandslund I. How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)? Clin Chem Lab Med 2005;43(4):403-411. (Pubitemid 41460647)
9. Denis MA, Reenaers C, Fontaine F, Belaïche J, Louis E. Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level. Inflamm Bowel Dis 2007;13(9):1100-1105. (Pubitemid 47402593)
10. Solem CA, Loftus EV, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 2005;11(8):707-712. (Pubitemid 41271173)
11. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Papamastorakis G, Prassopoulos P, Roussomoustakaki M. Assessment of Crohn's disease activity in the small bowel with MR and conventional enteroclysis: preliminary results. Eur Radiol 2004;14(6):1017-1024. (Pubitemid 38787247)
12. Malagò R, Manfredi R, Benini L, D'Alpaos G, Pozzi Mucelli R. Assessment of Crohn's disease activity in the small bowel with MRenteroclysis: clinico-radiological correlations. Abdom Imaging 2008;33(6):669-675.
13. Girometti R, Zuiani C, Toso F, et al. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum. Acad Radiol 2008;15(2):153-164.
14. Del Vescovo R, Sansoni I, Caviglia R, et al. Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease. Abdom Imaging 2008;33(4):417-424. (Pubitemid 351713068)
15. Taylor SA, Punwani S, Rodriguez-Justo M, et al. Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination - pilot study. Radiology 2009;251(2):369-379.
16. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55(6):749-753. (Pubitemid 43764536)
17. Ajaj W, Goyen M, Schneemann H, et al. Oral contrast agents for small bowel distension in MRI: influence of the osmolarity for small bowel distention. Eur Radiol 2005;15(7):1400-1406. (Pubitemid 40983523)
18. Meyers MA, McGuire PV. Spiral CT demonstration of hypervascularity in Crohn disease: "vascular jejunization of the ileum" or the "comb sign." Abdom Imaging 1995;20(4):327-332.
19. Borley NR, Mortensen NJ, Jewell DP,Warren BF. The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link. J Pathol 2000;190(2):196-202.
20. Chiorean MV, Sandrasegaran K, Saxena R, Maglinte DD, Nakeeb A, Johnson CS. Correlation of CT enteroclysis with surgical pathology in Crohn's disease. Am J Gastroenterol 2007;102(11):2541-2550. (Pubitemid 47631798)
21. White H. A hetroskedasticity-consistent convariance matrix estimator and a direct test for hetroskedasticity. Econometrica 1980;48(4):817-838.
22. Florie J. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn's disease. AJR Am J Roentgenol 2006;186(5):1384- 1392. (Pubitemid 46112577)
23. Gourtsoyiannis NC, Papanikolaou N, Karantanas A. Magnetic resonance imaging evaluation of small intestinal Crohn's disease. Best Pract Res Clin Gastroenterol 2006;20(1):137-156. (Pubitemid 43210631)
24. Shoenut JP, Semelka RC, Silverman R, Yaffe CS, Micflikier AB. Magnetic resonance imaging in inflammatory bowel disease. J Clin Gastroenterol 1993;17(1):73-78. (Pubitemid 23193783)
25. Koh DM, Miao Y, Chinn RJ, et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol 2001;177(6):1325-1332. (Pubitemid 33081474)
26. Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 2000;25(3):219-228. (Pubitemid 30304973)
27. Miao YM, Koh DM, Amin Z, et al. Ultrasound and magnetic resonance imaging assessment of active bowel segments in Crohn's disease. Clin Radiol 2002;57(10):913-918. (Pubitemid 35174555)
28. Pupillo VA, Di Cesare E, Frieri G, Limbucci N, Tanga M, Masciocchi C. Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI. Radiol Med 2007;112(6):798-809. (Pubitemid 350155022)
29. Wakefield AJ, Sawyerr AM, Dhillon AP, et al. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989;2(8671):1057-1062. (Pubitemid 19264073)
30. Masselli G, Manfredi R, Vecchioli A, Gualdi G. MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings. Eur Radiol 2008;18(10):2213-2221.